4.4 Editorial Material

If cancer stem cells are resistant to current therapies, what's next?

Related references

Note: Only part of the references are listed.
Article Biotechnology & Applied Microbiology

Oncolytic Reovirus Effectively Targets Breast Cancer Stem Cells

Paola Marcato et al.

MOLECULAR THERAPY (2009)

Review Medicine, General & Internal

Cancer, stem cells, and oncolytic viruses

Camilla Ribacka et al.

ANNALS OF MEDICINE (2008)

Article Biotechnology & Applied Microbiology

Oncolytic adenoviruses kill breast cancer initiating CD44+CD24-/Low cells

Minna Eriksson et al.

MOLECULAR THERAPY (2007)

Article Cell & Tissue Engineering

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

Christophe Ginestier et al.

CELL STEM CELL (2007)

Article Cell & Tissue Engineering

Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4

Matilde Todaro et al.

CELL STEM CELL (2007)

Article Oncology

The response of CD24-/low/CD44+ breast cancer-initiating cells to radiation

Tiffany M. Phillips et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)

Article Biochemistry & Molecular Biology

Analysis of gene expression and chemoresistance of CDI33+ cancer stem cells in glioblastoma

Gentao Liu et al.

MOLECULAR CANCER (2006)

Article Multidisciplinary Sciences

Prospective identification of tumorigenic breast cancer cells

M Al-Hajj et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Review Oncology

Multidrug resistance in cancer: Role of ATP-dependent transporters

MM Gottesman et al.

NATURE REVIEWS CANCER (2002)

Review Biochemistry & Molecular Biology

The hallmarks of cancer

D Hanahan et al.